2.17
price up icon0.93%   0.02
 
loading

Finanzdaten der Annexon Inc-Aktie (ANNX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
9.89%
51.73
57.41 39.44 33.58 28.57
Operating Income/Loss
9.89%
-51.73
-57.41 -39.44 -33.58 -28.57
Income/Loss From Continuing Operations Before Tax
9.57%
-49.16
-54.36 -34.82 -29.61 -25.18
Income/Loss From Continuing Operations After Tax
9.57%
-49.16
-54.36 -34.82 -29.61 -25.18
Net Income/Loss
9.57%
-49.16
-54.36 -34.82 -29.61 -25.18
Preferred Stock Dividends And Other Adjustments
1.857
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.14%
148.32
148.11 139.93 130.13 122.67
Diluted Average Shares
0.14%
148.32
148.11 139.93 130.13 122.67
Basic Earnings Per Share
8.11%
-0.34
-0.37 -0.25 -0.23 -0.21
Diluted Earnings Per Share
8.11%
-0.34
-0.37 -0.25 -0.23 -0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
1.857
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):